samedan logo
 
 
 
spacer
home > pmps > autumn 2008 > integrating isolation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Integrating Isolation

Remaining competitive in pharmaceutical development and production can be a challenge as it becomes more complex to get products through clinical trials and then to eventually produce them. In order to remain competitive, pharmaceutical companies need to develop products faster and more cost-effectively. At the same, time, they need to protect workers from increasingly hazardous drugs in both the clinical trials phase and during the manufacturing process.

In order to meet these trends costeffectively, many pharmaceutical companies will need to increase automation and flexibility within their facilities, while separating the production environment from operators. Combining these initiatives within a single technology platform is making it economically feasible to meet these challenges and still compete effectively.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Felix Nink studied Mechanical Engineering at Koblenz University. He has worked for Robert Bosch GmbH Packaging Technology since 2000, beginning his career as a Mechanical Designer in the capsule filling and checkweighing department. He gained experience as Application Engineer and Project Leader of several turnkey encapsulation projects for the pharmaceutical industry. Since 2004, Felix has been a Product Manager, with responsibility for capsule filling and checkweighing machines worldwide.
spacer
Felix Nink
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Stability Testing and Forced Degradation Stress Tests - Proactive Risk Management

Whereas the durability of many consumables, have a strong tendency to decrease, stability is and remains a crucial factor for pharmaceuticals. That is why the identification and elimination of factors, which put long-term stability at risk, is central during development – and an important requirement concerning the product’s quality.
More info >>

White Papers

The Promise and Challenge of Adaptive Design in Oncology Trials

Medpace

Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research. Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement